Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Sinclair Pharma (SPH) Share News

UK AGM, EGM Calendar - Week Ahead

29th Apr 2014 05:17

UK AGM, EGM Calendar - Week Ahead

28th Apr 2014 15:13

DIRECTOR DEALINGS: Sinclair IS Pharma Non-Executive Buys Shares

28th Apr 2014 12:01

LONDON (Alliance News) - Sinclair IS Pharma PLC Monday said non-executive Director Stuart Swanson bought 44,131 shares at 30.5 pence each Friday. Swanson also purchased 25,555 shares on Thursday, 35,000 shares on Wednesday, 19,089 shares on Tuesday and 50,000 shares April 17. Followin Read More

UK AGM, EGM Calendar - Week Ahead

28th Apr 2014 05:30

UK AGM, EGM Calendar - Week Ahead

25th Apr 2014 15:37

DIRECTOR DEALINGS: Sinclair IS Pharma Non-Executive Buys Shares

25th Apr 2014 11:53

LONDON (Alliance News) - Sinclair IS Pharma PLC Friday said non-executive Director Stuart Swanson bought 25,555 shares at a price of 30.5 pence per share Thursday. Swanson also purchased 35,000 shares on Wednesday, 19,089 shares on Tuesday and 50,000 shares April 17. Following the lat Read More

UK AGM, EGM Calendar - Week Ahead

25th Apr 2014 05:17

UK AGM, EGM Calendar - Week Ahead

24th Apr 2014 15:46

DIRECTOR DEALINGS: Sinclair Non-Executive Acquires Shares

23rd Apr 2014 11:44

LONDON (Alliance News) - Sinclair IS Pharma PLC said Wednesday that Non-Executive Director Stuart Swanson has acquired 19,089 shares at a price of 30.5 pence per share on Tuesday. Following this transaction, Swanson holds 4.3 million shares representing 0.99% in the pharmaceutical company.< Read More

DIRECTOR DEALINGS: Sinclair Non-Executive Acquires Shares

22nd Apr 2014 11:31

LONDON (Alliance News) - Sinclair IS Pharma PLC Tuesday said Non-Executive Director Stuart Swanson acquired 50,000 shares at a price of 30.50 pence per share on Thursday. Following this transaction, Swanson now has a beneficial interest in 4.3 million shares representing 0.98% of the pharma Read More

DIRECTOR DEALINGS: Sinclair IS Pharma Non-Exec Buys 35,000 Shares

22nd Apr 2014 06:31

LONDON (Alliance News) - Sinclair IS Pharma PLC Thursday said Non-Executive Director Stuart Swanson bought 35,000 shares at a price of 30.5 pence per share Wednesday, and now holds 4.2 million shares in total. The total excludes the 3.1 million placing shares for which Swanson has subscribe Read More

Sinclair IS Pharma In USD117.0 Million Deal For Silhouette

15th Apr 2014 15:41

LONDON (Alliance News) - Sinclair IS Pharma PLC Tuesday said it has agreed a deal to acquire private aesthetics company Silhouette for about USD117.0 million in cash plus royalties, in a move that will complete the build-out of the company's aesthetics business and enhance its technological posit Read More

Sinclair IS Pharma To Acquire Global Rights To Ellanse In AQTIS Medical Buy

1st Apr 2014 16:13

LONDON (Alliance News) - Sinclair IS Pharma PLC Tuesday said that its has entered into agreements to acquire the global rights to Ellanse, a combined dermal filler and collagen stimulator product range, through the acquisition of AQTIS Medical BV. The specialty pharmaceutical company said t Read More

Sinclair IS Pharma To Meet Full Year Expectations, Pretax Loss Narrows

25th Mar 2014 13:43

LONDON (Alliance News) - Sinclair IS Pharma PLC Tuesday said it expects its full-year results to meet market expectations, although it saw results "marginally behind expectations" in the half-year ended December 31, 2013. The company posted a pretax loss of GBP2.5 million, narrowed from a p Read More

UK Earnings, Trading Statements Calendar - Week Ahead

25th Mar 2014 06:12

UK Earnings, Trading Statements Calendar - Week Ahead

24th Mar 2014 15:39

Sinclair IS Burn Cream Flammacerium Granted Orphan Drug Designation By FDA

12th Mar 2014 10:31

LONDON (Alliance News) - Sinclair IS Pharma PLC said Wednesday that its dermal burn cream Flammacerium had been granted orphan drug designation by the US Food and Drug Administration. This designation grants Sinclair marketing exclusivity for seven years following approval. Sinclair n Read More

UK MORNING BRIEFING: Share Open Lower But Prudential Gains

12th Mar 2014 08:38

LONDON (Alliance News) - Share are lower at the open Wednesday, following Asian and US markets. Just after the open, insurer Prudential declared a 15% dividend increase for 2013. CEO Tidjane Thiam promised "more of the same, just better". It also announced an expand Read More

Sinclair IS Pharma Acquires Wrinkle Treatment Atlean From Glaxo

31st Jan 2014 09:00

LONDON (Alliance News) - Sinclair IS Pharma PLC said Friday that it had acquired dermal filler Atlean from GlaxoSmithKline PLC's dermatology business Stiefel. The company said that Atlean, used to reduce wrinkles, will complement its existing facial care brands Sculptra and Perfectha. Atlea Read More

UK MORNING BRIEFING: BT Earnings Give London Shares Positive Open

31st Jan 2014 08:22

LONDON (Alliance News) - A strong earnings report from BT Group has helped lift UK shares at the open Friday. The FTSE 100 telecom stock is up 3.7% at 384.60 pence. Brokers are providing their take on Thursday's corporate news makers, with Goldman Sach cutting <stro Read More

FTSE 100 Latest

Value8,809.74

Change53.53